Found: 97
Select item for more details and to access through your institution.
Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 6, p. 859, doi. 10.1007/s10637-009-9305-x
- By:
- Publication type:
- Article
Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models.
- Published in:
- Signal Transduction & Targeted Therapy, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41392-018-0010-0
- By:
- Publication type:
- Article
AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1378292
- By:
- Publication type:
- Article
Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38407-7
- By:
- Publication type:
- Article
A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 4, p. 346, doi. 10.1016/j.clpt.2006.06.009
- By:
- Publication type:
- Article
Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 3, p. 197, doi. 10.1016/j.clpt.2005.11.006
- By:
- Publication type:
- Article
Novel CYP2C9 genetic variants in asian subjects and their influence on maintenance warfarin dose<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 3, p. 210, doi. 10.1016/j.clpt.2004.05.005
- By:
- Publication type:
- Article
Risk factor modification in pre‐diabetic adults consuming white button mushrooms rich in the anti‐oxidant, ergothioneine (117.4).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.117.4
- By:
- Publication type:
- Article
A comparative study of dynamic contrast-enhanced MRI parameters as biomarkers for anti-angiogenic drug therapy.
- Published in:
- NMR in Biomedicine, 2011, v. 24, n. 9, p. 1169, doi. 10.1002/nbm.1680
- By:
- Publication type:
- Article
The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy.
- Published in:
- Medicinal Research Reviews, 2021, v. 41, n. 3, p. 1291, doi. 10.1002/med.21761
- By:
- Publication type:
- Article
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.
- Published in:
- Molecules, 2020, v. 25, n. 20, p. 4831, doi. 10.3390/molecules25204831
- By:
- Publication type:
- Article
Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.626659
- By:
- Publication type:
- Article
Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA.
- Published in:
- PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0267389
- By:
- Publication type:
- Article
Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 24, p. 9405, doi. 10.3390/ijms21249405
- By:
- Publication type:
- Article
Lack of somatic ErbB2 tyrosine kinase domain mutations in hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2008, v. 38, n. 8, p. 838, doi. 10.1111/j.1872-034X.2008.00365.x
- By:
- Publication type:
- Article
Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1261575
- By:
- Publication type:
- Article
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 6, p. 1, doi. 10.15252/emmm.201707945
- By:
- Publication type:
- Article
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1514, doi. 10.1038/s41416-023-02193-2
- By:
- Publication type:
- Article
The genomic landscape of nasopharyngeal carcinoma.
- Published in:
- Nature Genetics, 2014, v. 46, n. 8, p. 866, doi. 10.1038/ng.3006
- By:
- Publication type:
- Article
Role of computed tomography imaging in predicting response of nasopharyngeal carcinoma to definitive radiation therapy.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Role of Computed Tomography Imaging in Predicting Response of Nasopharyngeal Carcinoma to Definitive Radiation Therapy.
- Published in:
- Laryngoscope, 2006, v. 116, n. 12, p. 2162, doi. 10.1097/01.mlg.0000242046.22134.51
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor in Undifferentiated Carcinoma of the Nasopharynx.
- Published in:
- Laryngoscope, 2004, v. 114, n. 1, p. 153
- By:
- Publication type:
- Article
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 192, n. 1, p. 131, doi. 10.1007/s10549-021-06470-7
- By:
- Publication type:
- Article
Wanted DEAD/H or Alive: Helicases Winding Up in Cancers.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00356-6
- By:
- Publication type:
- Article
Profiling of 3D Genome Organization in Nasopharyngeal Cancer Needle Biopsy Patient Samples by a Modified Hi-C Approach.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.673530
- By:
- Publication type:
- Article
A Multiplex Thyroid-Specific Assay for Quantification of Circulating Thyroid Cell-Free RNA in Plasma of Thyroid Cancer Patients.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.721832
- By:
- Publication type:
- Article
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-09257-z
- By:
- Publication type:
- Article
Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 4, p. 818, doi. 10.1016/j.molonc.2014.12.008
- By:
- Publication type:
- Article
Re-irradiation versus Chemo-reirradiation for Recurrent, Unresectable Head and Neck Cancer.
- Published in:
- Otolaryngology-Head & Neck Surgery, 2013, v. 149, n. 2, p. P76, doi. 10.1177/0194599813495815a128
- By:
- Publication type:
- Article
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy.
- Published in:
- Journal of Extracellular Vesicles, 2022, v. 11, n. 4, p. 1, doi. 10.1002/jev2.12187
- By:
- Publication type:
- Article
Real-world assessment of attenuated dosing anti-PD1 therapy as an alternative dosing strategy in a high-income country (as defined by World Bank).
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.932212
- By:
- Publication type:
- Article
DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22638-7
- By:
- Publication type:
- Article
Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 22, p. 3152, doi. 10.1111/1759-7714.14667
- By:
- Publication type:
- Article
Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma.
- Published in:
- Acta Oncologica, 2009, v. 48, n. 4, p. 628, doi. 10.1080/02841860802637781
- By:
- Publication type:
- Article
Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma.
- Published in:
- Acta Oncologica, 2007, v. 46, n. 2, p. 234, doi. 10.1080/02841860600702076
- By:
- Publication type:
- Article
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.
- Published in:
- EMBO Molecular Medicine, 2013, v. 5, n. 7, p. 983, doi. 10.1002/emmm.201201823
- By:
- Publication type:
- Article
Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054522
- By:
- Publication type:
- Article
UGT1A6 Polymorphisms Modulated Lung Cancer Risk in a Chinese Population.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042873
- By:
- Publication type:
- Article
A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033183
- By:
- Publication type:
- Article
Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potential.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 11, p. 1789, doi. 10.1002/cncr.32069
- By:
- Publication type:
- Article
Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potential.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00635-5
- By:
- Publication type:
- Article
Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid Tumours.
- Published in:
- Scientific Reports, 2016, p. 27826, doi. 10.1038/srep27826
- By:
- Publication type:
- Article
Refining Dosing Strategies: Lessons From Singapore's Health Care System.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 20, p. 756
- By:
- Publication type:
- Article
Quantification of L-ergothioneine in human plasma and erythrocytes by liquid chromatography-tandem mass spectrometry.
- Published in:
- Journal of Mass Spectrometry, 2013, v. 48, n. 3, p. 406, doi. 10.1002/jms.3150
- By:
- Publication type:
- Article
Simultaneous determination of raltegravir and raltegravir glucuronide in human plasma by liquid chromatography-tandem mass spectrometric method.
- Published in:
- Journal of Mass Spectrometry, 2011, v. 46, n. 2, p. 202, doi. 10.1002/jms.1874
- By:
- Publication type:
- Article
Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.
- Published in:
- 2014
- By:
- Publication type:
- journal article